After the coronavirus pandemic raised its ugly head and started tormenting the world, the healthcare officials are clueless as to what medicines need to be used to heal the patients. Initially, they stated that Hydroxychloroquine showed a lot of promise. However, there are many who disagreed with the potency of the drug and expressed their apprehensions regarding its side effects. Recently, some pharma companies in India released some hitherto available drugs such as Favipiravir and Remdesivir which are repurposed to treat the coronavirus. Whenever a pharma company releases a new medicine, it is generating a lot of hope and people are celebrating the fact that one more medicine is available in the market. In spite of the availability of various medicines, none of them is proving to be a complete antidote to heal the coronavirus disease.
Therefore, humankind is waiting for the availability of a vaccine with bated breath. There are some universities, research organizations, and biotech companies that are doing commendable work to develop a vaccine to ward off the virus. The vaccine being developed by the University of Oxford appears to be showing a lot of promise, and as a result, emerged as a ray of hope for humankind. Even in India, the Hyderabad based Bharat Biotech has developed a vaccine, which is currently undergoing clinical trials. Though some vaccines that are being developed are showing promise, it is not yet known when exactly they will hit the market.
Even if these vaccines hit the market after successfully undergoing the clinical trials, it will be a herculean effort to produce the required number of doses for all the people in the world. Moreover, the vaccine may prove to be prohibitively expensive for many people, especially those who are below the poverty line. And, in all likelihood, the vaccine may initially become available in the developed world and it may take some time for it to reach the third world. Governments all over the world may have to subsidize the vaccine in order to bring it within the reach of the masses.
Though humanity is waiting for it with bated breath, as per many experts the vaccine will take at least another six months to reach the markets.
Many observers are predicting that India will play a crucial role in the development and manufacturing of the vaccine. India’s Serum Institute of India, which is the largest manufacturer of vaccines in the world, is expected to play a lead role in the production of the vaccine.
And vaccinating 135 crore population in India will require gargantuan resources and herculean efforts. All these factors are making many people skeptical about the prospect of warding off the virus with a vaccine.
Hence, the people, instead of lowering their guard on the expectation of getting a vaccine, should continue to observe all the required precautions to keep themselves safe from the potentially fatal virus.